Previous Close | 0.0615 |
Open | 0.0590 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0573 - 0.0660 |
52 Week Range | 0.0500 - 0.1200 |
Volume | |
Avg. Volume | 1,313,041 |
Market Cap | 57.452M |
Beta (5Y Monthly) | -0.13 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0090 |
Earnings Date | Aug 10, 2022 - Aug 15, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for KBLB
ANN ARBOR, Mich., July 06, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces that it has produced several new lines of larger hybrid Dragon SilkTM silkworms for its production operations in Vietnam. These new breeds of silkworms were explicitly created for large-scale production. With a larger cocoon and longer silk filament, these optimized Dra
ANN ARBOR, Mich., June 27, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces that, in collaboration with its joint venture partner, Kings Group, the Company has selected a high-quality garment manufacturer to produce Spydasilk'sTM first apparel line. Over the course of multiple meetings between Kraig Labs, Kings Group, and the garment manufactur
Kraig Labs Launches the Critical Next Phases of its Business Plan, Expanded Recombinant Spider Silk Production in Collaboration with Third-Party ContractorsHO CHI MINH CITY, Vietnam, June 21, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces the completion of its third-party pilot production. As a result of this highly successful program, Kraig